HIGHLIGHTS
- who: Nicholas Fuggle from the (UNIVERSITY) have published the paper: Novel formulations of oral bisphosphonates in the treatment of osteoporosis, in the Journal: (JOURNAL)
- what: Oral bisphosphonates play a key role in the treatment of osteoporosis and the amelioration of fracture risk.
- future: Research is required but there are signs that these novel oral bisphosphonate formulations may lead to improved tolerance of oral and thus improved adherence and outcomes.
SUMMARY
Depends on the side-chain length and they have substantial affinity for hydroxyapatite leading to inhibition osteoclast recruitment, osteoclast . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.